Insulin pump special eligibility criteria in New Zealand: a survey of prescriber opinion and practice.

Aim: Funding for insulin pump therapy (CSII) in New Zealand for people with type 1 diabetes is determined by meeting PHARMAC special authority (SA) criteria. We aimed to survey the opinion and practice of CSII prescribers with respect to the current SA criteria and contextualise the results with respect to contemporary literature and best practice.

Method: Quantitative and semi-qualitative survey of CSII prescribers in New Zealand.